Mood, affect and motivation in rehabilitation

Cognitive Neurorehabilitation

Volumn , Issue , 2015, Pages 205-217

  Ghaffar, Omar ^a   Feinstein, Anthony ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Neurology and clinical neuroscience; Neuropsychology

Indexed keywords

EID: 84954286458     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781316529898.016     Document Type: Chapter

References (91)

1. Adair, J. C., Williamson, D. J. G., Schwartz, R. L., & Heilman, K. M. (1996). Ventral tegmental area injury and frontal lobe disorder. Neurology, 46, 842-843.
2. Alexander, G. E., & Crutcher, M. D. (1990). Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends in Neurosciences, 13, 266-271.
3. Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357-381.
4. Arnett, P. A., Higginson, C. I., Voss, W. D. et al. (1999a). Depression in multiple sclerosis: relationship to working memory. Neuropsychology, 13, 546-556.
5. Arnett, P. A., Higginson, C. I., Voss, W. D. et al. (1999b). Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. Neuropsychology, 13, 434-446.
6. Bakshi, R., Czarnecki, D., Shaikh, Z. A. et al. (2000). Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport, 11, 1153-1158.
7. Barnhart, W. J., Makela, E. H., & Latocha, M. J. (2004). SSRIinduced apathy syndrome: a clinical review. Journal of Psychiatric Practice, 10, 196-199.
8. Barret, K. (1991). Treating organic abulia with bromocriptine and lisuride: four case studies. Journal of Neurology, Neurosurgery and Psychiatry, 56, 718-721.
9. Baxter, L. R., Schwartz, J. M., Phelps, M. E. et al. (1989). Reduction of prefrontal cortex metabolism common to three types of depression. Archives of General Psychiatry, 46, 243-250.
10. Beck, A. T., Steer, R. A., & Brown, G. K. (2000). DI-Fast Screen for Medical Patients. San Antonio, TX: The Psychological Corporation.
11. Bench, C. J., Friston, K. J., Brown, R. G. et al. (1992). The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychological Medicine, 22, 607-615.
12. Benedict, R. H., Wahlig, E., Bakshi, R. et al. (2005). Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. Journal of Neurological Sciences, 231, 29-34.
13. Benson, D. F., & Ardila, A. (1993). Depression in aphasia. In S. E. Starkstein & R. G. Robinson (Eds.), Depression in Neurologic Disease (pp.152-164). Baltimore, MD: Johns Hopkins Press.
14. Black, K. J., Hershey, T., Hartlein, J. M., Carl, J. L., & Perl-mutter, J. S. (2005). Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson’s disease. Neuropsychopharmacology, 30, 590-601.
15. Bressan, R. A., & Crippa, J. A. (2005). The role of dopamine in reward and pleasure behavior: review of data from preclinical research. Acta Psychiatrica Scandanavia, 427, 14-21.
16. Brooks, B. R., Thisted, R. A., Appel, S. H. et al. (2004). Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology, 63, 1364-1370.
17. Caine, E. D. (1981). Pseudodementia: current concepts and future directions. Archives of General Psychiatry, 38, 1359-1364.
18. Carson, A. J., MacHale, S., Allen, K. et al. (2000). Depression after stroke and lesion location: a systematic review. Lancet, 356, 122-126.
19. Castellon, S. A., Hardy, D. J., Hinkin, C. H. et al. (2006). Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance. Journal of Clinical and Experimental Neuropsychology, 28, 420-437.
20. Chamelian, L., & Feinstein, A. (2006). The effect of major depression on subjective and objective cognitive deficits in mild to moderate traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 33-38.
21. Clayton, P. J., & Lewis, C. E. (1981). The significance of secondary depression. Journal of Affective Disorders, 3, 25-35.
22. Cummings, J. L. (1985). Clinical Neuropsychiatry. Orlando, FL: Grune & Stratton.
23. Cummings, J. L. (1993). Frontal-subcortical circuits and human behaviour. Archives of Neurology, 50, 873-880.
24. Demaree, H. A., Gaudino, E., & DeLuca, J. (2003). The relationship between depressive symptoms and cognitive dysfunction in multiple sclerosis. Cognitive Neuropsychiatry, 8, 161-171.
25. Devinsky, O., Morrell, M. J., & Brent, A. V. (1995). Contributions of the anterior cingulate cortex to behaviour. Brain, 118, 279-306.
26. Eastwood, M. R., Rifat, S. L., Nobbs, H., & Ruderman, J. (1989). Mood disorder following CVA. British Journal of Psychiatry, 154, 195-200.
27. Fann, J. R., Uomoto, J. M., & Katon, W. J. (2001). Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics, 42, 48-54.
28. Feinstein, A. (2002). An examination of suicidal intent in patients with multiple sclerosis. Neurology, 59, 674-678.
29. Feinstein, A., Roy, P., Lobaugh, N. et al. (2004). Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology, 62, 586-590.
30. Folstein, S. E., Abbott, M. H., Chase, G. A., Jensen, B. A., & Folstein, M. F. (1983). The association of affective disorder with Huntington’s disease in a case series and in families. Psychological Medicine, 13, 537-541.
31. Friedenberg, D. L., & Cummings, J. L. (1989). Parkinson’s Disease, depression and the on-off phenomenon. Psychosomatics, 30, 94-99.
32. Frochtengarten, M. L., Villares, J. C. B., Maluf, E., & Carlini, E. A. (1987). Depressive symptoms and the dexamethasone suppression test in Parkinson patients. Biological Psychiatry, 22, 386-389.
33. Gaultieri, C. T., Johnson, L. G., & Benedict, K. B. (2006). Neurocognition in depression: patients on and off medication versus healthy comparison subjects. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 217-225.
34. George, M. S., Parekh, P. I., Rosinsky, N. et al. (1996). Understanding emotional prosody activates right hemisphere regions. Archives of Neurology, 53, 665-670.
35. Goldapple, K., Segal, Z., Garson, C. et al. (2004). Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry, 61, 34-41.
36. Greenberg, R. M., & Kellner, C. H. (2005). Electroconvulsive therapy: a selected review. American Journal of Geriatric Psychiatry, 13, 268-281.
37. Hall, R. C. W. (1980). Anxiety. In R. C. W. Hall (Ed.), Psychiatric Presentations of Medical Illness (pp. 13-32). New York, NY: Spectrum Publications Inc.
38. Hemeryck, A., & Belpaire, F. M. (2002). Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Current Drug Metabolism, 3, 13-37.
39. Hesdorffer, D. C., Hauser, W. A., Annegers, J. F., & Cascino, G. (2000). Major depression is a risk factor for seizures in older adults. Annals of Neurology, 47, 246-249.
40. Hoehn-Saric, R., Lipsey, J. R., & McLeod, D. R. (1990). Apathy and indifference in patients on fluvoxamine and fluoxetine. Journal of Clinical Psychopharmacology, 10, 343-345.
41. Holtzer, R., Scarmeas, N., Wegesin, D. J. et al. (2005). Depressive symptoms in Alzheimer’s disease: natural course and temporal relation to function and cognitive status. Journal of the American Geriatric Society, 53, 2083-2089.
42. Iannaccone, S., & Ferini-Strambi, L. (1996). Pharmacologic treatment of emotional lability. Clinical Neuropharmacology, 19, 532-535.
43. Jorge, R. E., & Starkstein, S. E. (2005). Pathophysiologic aspects of major depression following traumatic brain injury. Journal of Head Trauma and Rehabilitation, 20, 475-487.
44. Kessler, R. C., McGonagle, K. A., Zhao, S. et al. (1994). Lifetime and 12-month prevalence of DSM-111-R psychiatric disorders in the United States. Archives of General Psychiatry, 51, 8-19.
45. Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62, 617-627.
46. Larson, S. L., Owens, P. L., Ford, D., & Eaton, W. (2001). Depressive disorder, dysthymia and the risk of stroke: Thirteen-year follow-up from the Baltimore Epidemiological Catchment Area Study. Stroke, 32, 1979-1983.
47. Lauterbach, E. C., & Schweri, M. M. (1991). Amelioration of pseudobulbar affect by fluoxetine: possible alteration of dopamine-related pathophysiology by a selective serotonin reuptake inhibitor. Journal of Clinical Psychopharmacology, 11, 392-393.
48. Leentgens, A. F. G., VanDer Akker, M., Metsemakers, J. F. M., Lousberg, R., & Verhey, F. R. J. (2003). Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Movement Disorders, 18, 414-418.
49. Lieberman, A. (2006). Depression in Parkinson’s disease: a review. Acta Neurologica Scandanavia, 113, 1-8.
50. Loreck, D. J., & Folstein, M. F. (1993). Depression in Alzheimer’s disease. In S. E. Starkstein & R. G. Robinson (Eds.), Depression and Neurologic Disease (pp. 50-62). Baltimore, MD: Johns Hopkins Press.
51. Marin, R. S. (1990). Differential diagnosis and classification of apathy. American Journal of Psychiatry, 147, 22-30.
52. Marin, R. S. (1991). Apathy: a neuropsychiatric syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 3, 243-254.
53. Marin, R. S. (1996). Apathy: concept, syndrome, neural mechanisms, and treatment. Seminars in Clinical Neuropsychiatry, 1, 304-314.
54. Marin, R. S., & Wilkosz, P. A. (2005). Disorders of diminished motivation. Journal of Head Trauma Rehabilitation, 20, 377-388.
55. Marin, R. S., Firinciogullari, S., & Biedrzycki, R. C. (1994). Group differences in the relationship between apathy and depression. Journal of Nervous and Mental Disease, 183, 235-239.
56. Marin, R. S., Fogel, B. S., Hawkins, J., Duffy, J., & Krupp, B. (1995). Apathy: a treatable syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 7, 23-30.
57. Marin, R. S., Butters, M. A., Mulsant, B. H., Pollock, B. G., & Reynolds, C. F. R. (2003). Apathy and executive function in depressed elderly. Journal of Geriatric Psychiatry and Neurology, 16, 112-116.
58. Mayberg, H. S. (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin, 65, 193-207.
59. Mayberg, H. S., Starkstein, S. E., Sadzot, B. et al. (1990). Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Annals of Neurology, 28, 57-64.
60. Mayberg, H. S., Starkstein, S. E., Peyser, C. E. et al. (1992). Paralimbic frontal hypometabolism in depression associated with Huntington’s Disease. Neurology, 42, 1791-1797.
61. Miller, A. (2006). Pseudobulbar affect in multiple sclerosis: toward the development of innovative therapeutic strategies. Journal of Neurological Sciences, 245, 153-159.
62. Miyasaki, J. M., Shannon, K., Voon, V. et al. (2006). Practice parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidencebased review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 66, 996-1002.
63. Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001). Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology, 69, 942-949.
64. Moriarty, J. (2005). Recognising and evaluating disordered mental states: a guide for neurologists. Journal of Neurology, Neurosurgery and Psychiatry, 76, i39-i44.
65. Padala, P. R., Petty, F., & Bhatia, S. C. (2005). Methylphenidate may treat apathy independent of depression. Annals of Pharmacotherapy, 39, 1947-1949.
66. Panitch, H. S., Thisted, R. A., Smith, R. A. et al. (2006). Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Annals of Neurology, 59, 780-787.
67. Patten, S. B., Beck, C. A., Williams, J. V., Barbui, C., & Metz, L. M. (2003). Major depression in multiple sclerosis: a population-based perspective. Neurology, 61, 1524-1527.
68. Paulsen, J. S., Nehl, C., Hoth, K. F. et al. (2005). Depression and stages of Huntington’s disease. Journal of Neuropsychiatry and Clinical Neuroscience, 17, 496-502.
69. Poeck, K. (1969). Pathophysiology of emotional disorders associated with brain damage. In P. J. Vinken & G. W. Bruyn (Eds.), Handbook of Clinical Neurology, Vol. 3 (pp. 343-367). Amsterdam, NL: North Holland Publishing Company.
70. Popkin, M. K., & Tucker, G. J. (1994). Mental disorders due to a general medical condition. Mood, anxiety, psychotic, catatonic and personality disorders. In T. A. Widiger (Ed.), DSM-IV Sourcebook, Vol. 1 (pp. 243-276). Washington, DC: American Psychiatric Association.
71. Pujol, J., Bello, J., Deus, J., Marti-Vilalta, J. L., & Capdevila, A. (1997). Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology, 49, 1105-1110.
72. Robbins, T. W. (2005). Chemistry of the mind: neurochemical modulation of prefrontal cortical function. Journal of Comparative Neurology, 493, 140-146.
73. Robinson, R. G. (2003). Poststroke depression: prevalence, diagnosis, treatment and disease progression. Biological Psychiatry, 54, 376-387.
74. Robinson, R. G., & Price, T. R. (1982). Post stroke depressive disorders: a follow-up study of 103 patients. Stroke, 13, 635-641.
75. Robinson, R. G., Kubos, K. L., Starr, L. B., Rao, K., & Price, T. R. (1983). Mood changes in stroke patients: relationship to lesion location. Comprehensive Psychiatry, 24, 555-566.
76. Robinson, R. G., & Jorge, R. E. (1994). Mood disorders. In J. M. Silver, S. C. Yudofsky & R. E. Hales (Eds.), Neuropsychiatry of Traumatic Brain Injury. Washington, DC: American Psychiatric Press.
77. Ross, E. D., & Stewart, R. M. (1981). Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists. Neurology, 31, 1435-1439.
78. Ross, E. D., & Stewart, R. S. (1987). Pathological display of affect in patients with depression and right frontal brain damage. Journal of Nervous and Mental Disease, 175, 165-172.
79. Sadovnick, A. D., Remick, R. A., Allen, J. et al. (1996). Depression and multiple sclerosis. Neurology, 46, 628-632.
80. Schiffer, R. B., Herndon, R. M., & Rudick, R. A. (1985). Treatment of pathological laughing and weeping with amitriptyline. NewEngland Journal ofMedicine, 312, 1480-1482.
81. Schiffer, R. B., Wineman, N. M., & Weitkamp, L. R. (1986). Association between bipolar affective disorder and multiple sclerosis. American Journal of Psychiatry, 143, 94-95.
82. Schiffer, R. B., Weitkamp, L. R., Wineman, N. M., & Guttormsen, S. (1988). Multiple sclerosis and affective disorder: family history, sex, and HLA-DR antigens. Archives of Neurology, 45, 1345-1348.
83. Seminowicz, D. A., Mayberg, H. S., McIntosh, A. R. et al. (2004). Limbic-frontal circuitry in major depression: a path modeling metanalysis. NeuroImage, 22, 409-418.
84. Singh, A., Herrmann, N., & Black, S. E. (1998). The importance of lesion location in poststroke depression: a critical review. Canadian Journal of Psychiatry, 43, 921-927.
85. Starkstein, S. E., & Robinson, R. G. (1989). Depression and Parkinson’s disease. In R. G. Robinson & P. V. Rabins (Eds.), Aging and Clinical Practice: Depression and Co-existing Disease (pp. 213-248). New York, NY: Igaku-Shoi.
86. Starkstein, S. E., Robinson, R. G., & Price, T. R. (1987). Comparison of cortical and subcortical lesions in the production of post-stroke mood disorders. Brain, 110, 1045-1059.
87. Stefurak, T. L., New, P., Mahurin, R. K. et al. (2001). Response specific regional metabolic changes with fluoxetine treatment in depressed Parkinson’s patients. Movement Disorders, 16, S39.
88. Stenager, E. N., & Stenager, E. (1992). Suicide and patients with neurologic disease. Archives of Neurology, 49, 1296-1303.
89. Tekin, S., & Cummings, J. L. (2002). Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. Journal of Psychosomatic Research, 53, 647-654.
90. Wing, J.K., & Brown, G.W. (1970). Institutionalism and Schizophrenia. Cambridge, UK: Cambridge University Press.
91. Wolf, J. K., Santana, H. B., & Thorpy, M. (1979). Treatment of emotional incontinence with levodopa. Neurology, 29, 1435-1436.